CBD compounds may inhibit COVID infection

It is being reported that 2 compounds in Hemp may inhibit Covid infection by binding to the spike protein of the virus to making it unable to attach to human cells.

COVID-19 may be blocked by cannabis compounds, study says

2 Likes

Cool!

I can’t wait to get some edibles!

Known since 2020, but to hell with effective medicine already available throughout human history. Vaxshine!

Don’t forget our good friend THC preventing ARDS.

2 Likes

What an absolute gift to man, that plant.

1 Like

Funny you posted this…Was coughing pretty bad Thursday night, had an edible and that really seemed to calm it down.

1 Like

Agreed.

moon

It’s the medicine that keeps on curing.

Cannabis kills tumor cells
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism - PMC
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas - PubMed
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas - PubMed
Cannabinoid receptor systems: therapeutic targets for tumour intervention - PubMed
Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans - PubMed
Hypothesis: cannabinoid therapy for the treatment of gliomas? - PubMed
Involvement of cannabinoids in cellular proliferation - PubMed
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes - PubMed
Cannabinoids and gliomas - PubMed
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas - PubMed
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells - PubMed
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway - PubMed
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation - PubMed
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? - PubMed
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines - PubMed
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review) - PubMed
Cannabinoid receptors in human astroglial tumors - PubMed
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor - PubMed

Uterine, testicular, and pancreatic cancers
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page4
Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids - PubMed

Brain cancer
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor - PubMed

Mouth and throat cancer
Cannabinoids inhibit cellular respiration of human oral cancer cells - PubMed

Breast cancer
JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells - PubMed
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma - PubMed
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation - PubMed

Lung cancer
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1 - PubMed
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1 - PubMed
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis - PubMed

Prostate cancer
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production - PubMed
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications - PMC
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms - PubMed
Cannabinoid receptor as a novel target for the treatment of prostate cancer - PubMed
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism - PubMed
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2 - PubMed

Blood cancer
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease - PubMed
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria - PubMed

Skin cancer
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors - PubMed
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities - PubMed

Liver cancer
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy - PubMed

Cannabis cancer cures (general)
Inhibition of tumor angiogenesis by cannabinoids - PubMed
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas - PubMed
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival - PubMed
Cannabinoids for cancer treatment: progress and promise - PubMed
Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? - PubMed
Cannabinoids and cell fate - PubMed
Cannabinoids in the treatment of cancer - PubMed
[The endocannabinoid system as a target for the development of new drugs for cancer therapy] - PubMed
Cannabinoids and cancer - PubMed
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor - PubMed

Cancers of the head and neck
http://ww.ncbi.nlm.nih.gov/pmc/articles/PMC2277494

Cholangiocarcinoma cancer
http://ww.ncbi.nlm.nih.gov/pubmed/19916793
http://www.ncbi.nlm.nih.gov/pubmed/21115947

Leukemia
http://www.ncbi.nlm.nih.gov/pubmed/15454482
http://www.ncbi.nlm.nih.gov/pubmed/16139274
http://www.ncbi.nlm.nih.gov/pubmed/14692532

Cannabis partially/fully induced cancer cell death
http://www.ncbi.nlm.nih.gov/pubmed/12130702
http://www.ncbi.nlm.nih.gov/pubmed/19457575
http://www.ncbi.nlm.nih.gov/pubmed/18615640
http://www.ncbi.nlm.nih.gov/pubmed/17931597
http://www.ncbi.nlm.nih.gov/pubmed/18438336
http://www.ncbi.nlm.nih.gov/pubmed/19916793
http://www.ncbi.nlm.nih.gov/pubmed/18387516
http://www.ncbi.nlm.nih.gov/pubmed/15453094
http://www.ncbi.nlm.nih.gov/pubmed/19229996
http://www.ncbi.nlm.nih.gov/pubmed/9771884
http://www.ncbi.nlm.nih.gov/pubmed/18339876
http://www.ncbi.nlm.nih.gov/pubmed/12133838
http://www.ncbi.nlm.nih.gov/pubmed/16596790
http://www.ncbi.nlm.nih.gov/pubmed/11269508
http://www.ncbi.nlm.nih.gov/pubmed/15958274
http://www.ncbi.nlm.nih.gov/pubmed/19425170
http://www.ncbi.nlm.nih.gov/pubmed/17202146
http://www.ncbi.nlm.nih.gov/pubmed/11903061
http://www.ncbi.nlm.nih.gov/pubmed/15451022
http://www.ncbi.nlm.nih.gov/pubmed/20336665
http://www.ncbi.nlm.nih.gov/pubmed/19394652
http://www.ncbi.nlm.nih.gov/pubmed/11106791
http://www.ncbi.nlm.nih.gov/pubmed/19189659
http://www.ncbi.nlm.nih.gov/pubmed/16500647
http://www.ncbi.nlm.nih.gov/pubmed/19539619
http://www.ncbi.nlm.nih.gov/pubmed/19059457
http://www.ncbi.nlm.nih.gov/pubmed/16909207
http://www.ncbi.nlm.nih.gov/pubmed/18088200
http://www.ncbi.nlm.nih.gov/pubmed/10913156
http://www.ncbi.nlm.nih.gov/pubmed/18354058
http://www.ncbi.nlm.nih.gov/pubmed/19189054
http://www.ncbi.nlm.nih.gov/pubmed/17934890
http://www.ncbi.nlm.nih.gov/pubmed/16571653
http://www.ncbi.nlm.nih.gov/pubmed/19889794
http://www.ncbi.nlm.nih.gov/pubmed/15361550

Translocation-positive rhabdomyosarcoma
http://www.ncbi.nlm.nih.gov/pubmed/19509271

Lymphoma
http://www.ncbi.nlm.nih.gov/pubmed/18546271
http://www.ncbi.nlm.nih.gov/pubmed/16936228
http://www.ncbi.nlm.nih.gov/pubmed/16337199
http://www.ncbi.nlm.nih.gov/pubmed/19609004

Cannabis kills cancer cells
http://www.ncbi.nlm.nih.gov/pubmed/16818634
http://www.ncbi.nlm.nih.gov/pubmed/12648025
Cannabinoids and gliomas - PubMed
http://www.ncbi.nlm.nih.gov/pubmed/16835997

Melanoma
http://www.ncbi.nlm.nih.gov/pubmed/17065222

Thyroid carcinoma
http://www.ncbi.nlm.nih.gov/pubmed/18197164

Colon cancer
http://www.ncbi.nlm.nih.gov/pubmed/18938775
http://www.ncbi.nlm.nih.gov/pubmed/19047095

Intestinal inflammation and cancer
http://www.ncbi.nlm.nih.gov/pubmed/19442536

Cannabinoids in health and disease
http://www.ncbi.nlm.nih.gov/pubmed/18286801

Cannabis inhibits cancer cell invasion
http://www.ncbi.nlm.nih.gov/pubmed/19914218

Anorexia
Emesis
Pain
Inflammation
Multiple Sclerosis
Parkinson’s Disease
Huntington’s Disease
Tourette’s Syndrome
Alzheimer’s Disease
Epilepsy
Glaucoma
Osteoporosis
Schizophrenia
Cardiovascular Disorders
Cancer
Obesity
Metabolic Syndrome-Related Disorders

Tip of the iceberg. There’s a lot more too, being that your body’s natural CBD-2 receptors are found throughout your immune system. :+1:

PS - if you’ve ever been breast-fed, you were high on Anandamide the day you were born. :wink: